SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 12, 2000, Pages 4797-4802

Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil

(5) Aschele, Carlo a Debernardis, Domizia b Tunesi, Gianni c Maley, Frank e Sobrero, Alberto d

a AO Di Padova (Italy)

b UNIVERSITY OF GENOA (Italy)

c GALLIERA HOSPITAL (Italy)

d UNIVERSITY OF UDINE (Italy)

e WADSWORTH CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PROTEIN P53; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER RESISTANCE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS POTENTIAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECOMBINANT PROTEINS; RECTAL NEOPLASMS; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034486207 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (98)

References (45)

1
- 0030966645
- Colorectal cancer - Is there an alternative to 5-FU?
- (1997) Eur. J. Cancer , vol.33 , pp. 536-541
- Bleiberg, H.¹

2
- 0024539308
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma
- A Mid-Atlantic Oncology Program Study
- (1989) J. Clin. Oncol. , vol.7 , pp. 425-432
- Lokich, J.J.¹ Ahlgren, J.D.² Gullo, J.J.³ Philips, J.A.⁴ Fryer, J.G.⁵

3
- 0026721532
- Advanced colorectal cancer meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
- (1992) J. Clin. Oncol. , vol.10 , pp. 896-903

4
- 0031014682
- Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors
- (1997) J. Clin. Oncol. , vol.15 , pp. 389-400
- Rustum, Y.M.¹ Harstrick, A.² Cao, S.³ Vanhoefer, U.⁴ Yin, M.B.⁵ Wilke, H.⁶ Seeber, S.⁷

5
- 9044245305
- ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer
- Tomudex Colorectal Study Group
- (1996) J. Clin. Oncol. , vol.14 , pp. 716-721
- Zalcberg, J.R.¹ Cunningham, D.² Van Cutsem, E.³ Francois, E.⁴ Schornagel, J.⁵ Adenis, A.⁶ Green, M.⁷ Iveson, A.⁸ Azab, M.⁹ Seymour, I.¹⁰

6
- 0033238019
- Oral fluoropyrimidines
- (1999) Semin. Oncol. , vol.26 , pp. 640-646
- Hoff, P.M.¹ Royce, M.² Medgyesy, D.³ Brito, R.⁴ Pazdur, R.⁵

7
- 0027408915
- Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: A phase II study in patients with disseminated colorectal cancer
- (1993) J. Natl. Cancer Inst. , vol.85 , pp. 41-44
- Leichman, C.G.¹ Leichman, L.² Spears, C.P.³ Rosen, P.J.⁴ Jeffers, S.⁵ Groshen, S.⁶

8
- 0031019918
- A randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
- (1997) J. Clin. Oncol. , vol.15 , pp. 808-815
- De Gramont, A.¹ Bosset, J.F.² Milan, C.³ Rougier, P.⁴ Bouche, O.⁵ Etienne, P.L.⁶ Morvan, F.⁷ Louvet, C.⁸ Guillot, T.⁹ Francois, E.¹⁰ Bedenne, L.¹¹

9
- 9444270969
- Modulation of high dose infusional fluorouracil by low dose methotrexate in patients with advanced or metastatic colorectal cancer: Final results of a randomized European Organization for Research and Treatment of Cancer Study
- (1996) J. Clin. Oncol. , vol.14 , pp. 2266-2273
- Blijham, G.¹ Wagener, T.² Wils, J.³ De Greve, J.⁴ Buset, M.⁵ Bleiberg, H.⁶ Lacave, A.⁷ Dalmark, M.⁸ Selleslag, J.⁹ Collette, L.¹⁰ Sahmoud, T.¹¹

10
- 0030154340
- High-dose infusional 5-FU in the treatment of advanced colorectal cancer: A summary of the European experience
- (1996) J. Infus. Chemother. , vol.6 , pp. 145-148
- Wils, J.A.¹

11
- 5544237608
- Final results of a randomized trial comparing "Tomudex" (Raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
- "Tomudex" Colorectal Cancer Study Group
- (1996) Ann. Oncol. , vol.7 , pp. 961-965
- Cunningham, D.¹ Zalcberg, J.R.² Rath, U.³ Oliver, I.⁴ Van Cutsem, E.⁵ Svensson, C.⁶ Seitz, J.F.⁷ Harper, P.⁸ Kerr, D.⁹ Perez-Manga, G.¹⁰

12
- 0031671255
- Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer
- Tomudex Colorectal Cancer Study Group
- (1998) J. Clin. Oncol. , vol.16 , pp. 2943-2952
- Cocconi, G.¹ Cunningham, D.² Van Cutsem, E.³ Francois, E.⁴ Gustavsson, B.⁵ Van Hazel, G.⁶ Kerr, D.⁷ Possinger, K.⁸ Hietschold, S.M.⁹

13
- 0012797224
- Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
- (1996) Ann. Oncol. , vol.7 , pp. 95-98
- Machover, D.¹ Diaz-Rubio, E.² De Gramont, A.³ Schilf, A.⁴ Gastiaburu, J.-J.⁵ Brienza, S.⁶ Itzhaki, M.⁷ Metzger, G.⁸ N’Daw, D.⁹ Vignoud, J.¹⁰ Abad, A.¹¹ Francois, E.¹² Gamelin, E.¹³ Marty, M.¹⁴ Sastre, J.¹⁵ Seitz, J.F.¹⁶ Ychou, M.¹⁷

14
- 0004700371
- Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study
- (1998) Ann. Oncol. , vol.9 , pp. 105-108
- Diaz-Rubio, E.¹ Sastre, J.² Zaniboni, A.³ Labianca, R.⁴ Cortes-Funes, H.⁵ De Braud, F.⁶ Boni, C.⁷ Benavides, M.⁸ Dallavalle, G.⁹ Homerin, M.¹⁰

15
- 0027310715
- Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
- (1993) Eur. J. Cancer , vol.29 A , pp. 1280-1284
- Levi, F.¹ Perpoint, B.² Garufi, C.³ Focan, C.⁴ Chollet, P.⁵ Depres-Brummer, P.⁶ Zidani, R.⁷ Brienza, S.⁸ Itzhaki, M.⁹ Iacobelli, S.¹⁰

16
- 0029919598
- Irinotecan is an active agent in untreated patients with metastatic colorectal cancer
- (1996) J. Clin. Oncol. , vol.14 , pp. 709-715
- Conti, J.A.¹ Kemeny, N.E.² Saltz, L.B.³ Huang, Y.⁴ Tong, W.P.⁵ Chou, T.C.⁶ Sun, M.⁷ Pulliam, S.⁸ Gonzales, C.⁹

17
- 0029966672
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
- (1996) J. Clin. Oncol. , vol.14 , pp. 1128-1135
- Rothemberg, M.L.¹ Eckardt, J.R.² Kuhn, J.G.³ Burris, H.A.⁴ Nelson, J.⁵ Hilsenbeck, S.G.⁶ Rodriguez, G.I.⁷ Thurman, A.M.⁸ Smith, L.S.⁹ Eckhardt, S.G.¹⁰ Weiss, G.R.¹¹ Elfring, G.L.¹² Rinaldi, D.A.¹³ Schaaf, L.J.¹⁴ Von Hoff, D.D.¹⁵

18
- 0031014627
- Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
- (1997) J. Clin. Oncol. , vol.15 , pp. 251-260
- Rougier, P.¹ Bugat, R.² Douillard, J.Y.³ Culine, S.⁴ Suc, E.⁵ Brunet, P.⁶ Becouarn, Y.⁷ Ychou, M.⁸ Marty, M.⁹ Extra, J.M.¹⁰ Bonneterre, J.¹¹ Adenis, A.¹² Seitz, J.F.¹³ Ganem, G.¹⁴ Namer, M.¹⁵ Conroy, T.¹⁶ Negrier, S.¹⁷ Merrouche, Y.¹⁸ Burki, F.¹⁹ Mousseau, M.²⁰ Herait, P.²¹ Mahjoubi, M.²² more..

19
- 0032585197
- Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
- (1998) Lancet , vol.352 , pp. 1407-1412
- Rougier, P.¹ Van Cutsem, E.² Bajetta, E.³ Niederle, N.⁴ Possinger, K.⁵ Labianca, R.⁶ Navarro, M.⁷ Morant, R.⁸ Bleiberg, H.⁹ Wils, J.¹⁰ Awad, L.¹¹ Herait, P.¹² Jacques, C.¹³

20
- 0032585232
- Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
- (1998) Lancet , vol.352 , pp. 1413-1418
- Cunningham, D.¹ Pyrhonen, S.² James, R.D.³ Punt, C.J.⁴ Hickish, T.F.⁵ Heikkila, R.⁶ Johannesen, T.B.⁷ Starkhammar, H.⁸ Topham, C.A.⁹ Awad, L.¹⁰ Jacques, C.¹¹ Herait, P.¹²

21
- 0028224082
- Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma
- (1994) Lancet , vol.343 , pp. 1177-1183
- Riethmuller, G.¹ Schneider-Gadicke, E.² Schlimok, G.³ Schmiegel, W.⁴ Raab, R.⁵ Hoffken, K.⁶ Gruber, R.⁷ Pichlmaier, H.⁸ Hirche, H.⁹ Pichlmayr, R.¹⁰ Buggisch, P.¹¹ Witte, J.¹²

22
- 0021335983
- Increased levels of thymidylate synthase in cells exposed to 5-fluorouracil
- (1984) Mol. Pharmacol. , vol.25 , pp. 171-177
- Washtien, W.L.¹

23
- 0022344622
- Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells
- (1985) Mol. Pharmacol. , vol.28 , pp. 461-467
- Berger, S.H.¹ Jenh, C.H.² Johnson, L.F.³ Berger, F.G.⁴

24
- 0026030052
- Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines
- (1991) Mol. Pharmacol. , vol.39 , pp. 136-143
- Chu, E.¹ Drake, J.C.² Koeller, D.M.³ Zinn, S.⁴ Jamis-Dow, C.A.⁵ Yeh, G.C.⁶ Allegra, C.J.⁷

25
- 0023111335
- Thymidylate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy
- (1997) Cancer Treat. Rep. , vol.71 , pp. 261-265
- Clark, J.L.¹ Berger, S.H.² Mittelman, A.³ Berger, F.G.⁴

26
- 0028019880
- Thymidylate synthase inhibition after administration of fluorouracil with and without leucovorin in colon cancer patients: Implication for treatment with fluorouracil
- (1994) J. Clin. Oncol. , vol.12 , pp. 2035-2042
- Peters, G.J.¹ Van Der Wilt, C.L.² Van Groeningen, C.J.³ Smid, K.⁴ Meijer, S.⁵ Pinedo, H.M.⁶

27
- 0029156922
- Thymidylate synthase and drug resistance
- (1995) Eur. J. Cancer , vol.31 A , pp. 1299-1305
- Peters, G.J.¹ Van Der Wilt, C.L.² Van Triest, B.³ Codacci-Pisanelli, G.⁴ Johnston, P.G.⁵ Van Groeningen, C.J.⁶ Pinedo, H.M.⁷

28
- 0030883708
- Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin
- (1997) J. Clin. Oncol. , vol.15 , pp. 3223-3229
- Leichman, C.G.¹ Lenz, H.J.² Leichman, L.³ Danenberg, K.⁴ Baranda, J.⁵ Groshen, S.⁶ Boswell, W.⁷ Metzger, R.⁸ Tan, M.⁹ Danenberg, P.V.¹⁰

29
- 0032997572
- Immunohistochemical quantitation of thymidylate synthase predicts for clinical outcome in patients with advanced colorectal cancer treated by alternated bolus and infusional 5-fluorouracil
- (1999) J. Clin. Oncol. , vol.17 , pp. 1760-1770
- Aschele, C.¹ Debernardis, D.² Casazza, S.³ Antonelli, G.⁴ Tunesi, G.⁵ Baldo, C.⁶ Lionetto, R.⁷ Maley, F.⁸ Sobrero, A.⁹

30
- 0033009501
- Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine
- (1999) Clin. Cancer Res. , vol.5 , pp. 325-328
- Davies, M.M.¹ Johnston, P.G.² Kaur, S.³ Allen Mersh, T.G.⁴

31
- 0345973521
- Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy
- (1997) Cancer Lett. , vol.118 , pp. 29-35
- Kornmann, M.¹ Link, K.H.² Lenz, H.J.³ Pillasch, J.⁴ Metzger, R.⁵ Butzer, U.⁶ Leder, G.H.⁷ Weindel, M.⁸ Safi, F.⁹ Danenberg, K.D.¹⁰ Beger, H.G.¹¹ Danenberg, P.V.¹²

32
- 6544276581
- Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil
- (1999) Clin. Cancer Res. , vol.5 , pp. 1996-1999
- Cascinu, S.¹ Aschele, C.² Barni, S.³ Debernardis, D.⁴ Baldo, C.⁵ Tunesi, G.⁶ Catalano, V.⁷ Staccioli, M.P.⁸ Brenna, A.⁹ Muretto, P.¹⁰ Catalano, G.¹¹

33
- 0029099290
- Schedule-selective biochemical modulation of 5-fluorouracil: A phase II study in advanced colorectal cancer
- (1995) Clin. Cancer Res. , vol.1 , pp. 955-960
- Sobrero, A.F.¹ Aschele, C.² Guglielmi, A.P.³ Mori, A.M.⁴ Tixi, L.M.⁵ Bolli, E.A.⁶ Rosso, R.⁷ Mammoliti, S.⁸ Rollandi, G.A.⁹ Bertoglio, S.¹⁰ Bruzzi, P.¹¹ Bertino, J.R.¹²

34
- 14444267315
- Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A multicentric phase II study
- (1998) Br. J. Cancer , vol.77 , pp. 341-346
- Aschele, C.¹ Guglielmi, A.² Frassineti, G.L.³ Milandri, C.⁴ Amadori, D.⁵ Labianca, R.⁶ Vinci, M.⁷ Tixi, L.⁸ Caroti, C.⁹ Ciferri, E.¹⁰ Verdi, E.¹¹ Rosso, R.¹² Sobrero, A.¹³

35
- 0019492861
- A comparative study of the peroxidase-antiperoxidase method and an avidin biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies
- (1981) Am. J. Clin. Pathol. , vol.5 , pp. 734-738
- Hsu, S.M.¹ Raine, L.² Fanger, H.³

36
- 14444285483
- p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival
- (1998) Clin. Cancer Res. , vol.4 , pp. 1243-1250
- Lenz, H.J.¹ Hayashi, K.² Salonga, D.³ Danenberg, K.D.⁴ Danenberg, P.V.⁵ Metzger, R.⁶ Banerjee, D.⁷ Bertino, J.R.⁸ Groshen, S.⁹ Leichman, L.P.¹⁰ Leichman, C.G.¹¹

37
- 0031053520
- Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy
- (1997) Br. J. Cancer , vol.75 , pp. 903-909
- Findlay, M.P.N.¹ Cunningham, D.² Morgan, G.³ Clinton, S.⁴ Hardcastle, A.⁵ Aherne, G.W.⁶

38
- 0019842734
- Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy
- (1981) Lancet , vol.2 , pp. 1317-1319
- Campbell, F.C.¹ Elston, C.W.² Blamey, R.W.³ Morris, A.H.⁴ Nicholson, R.I.⁵ Griffiths, K.⁶ Haybitlle, J.L.⁷

39
- 0019312387
- Hormonal receptors in primary and advanced breast cancer
- (1980) Clin. Endocrinol. Metab. , vol.9 , pp. 361-368
- Knight, W.A.¹ Osborne, C.K.² McGuire, W.L.³

40
- 0031947357
- Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma
- (1998) J. Clin. Oncol. , vol.16 , pp. 1465-1469
- Gorlick, R.¹ Metzger, R.² Danenberg, D.³ Salonga, D.⁴ Miles, J.S.⁵ Longo, G.S.A.⁶ Fu, J.⁷ Banerjee, D.⁸ Klimstra, D.⁹ Jhanwar, S.¹⁰ Davenberg, P.V.¹¹ Kemeny, N.¹² Bertino, J.¹³

41
- 9844229067
- A prospective randomized trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer
- (1997) Ann. Oncol. , vol.8 , pp. 995-1001
- Ross, P.¹ Norman, A.² Cunningham, D.³ Webb, A.⁴ Iveson, T.⁵ Padhani, A.⁶ Prendiville, J.⁷ Watson, M.⁸ Massey, A.⁹ Popescu, R.¹⁰ Oates, J.¹¹

42
- 0000449676
- A randomized trial of leucovorin (LV) and 5-fluorouracil (5FU) with or without oxaliplatin in advanced colorectal cancer (CRC)
- abs985
- (1998) Proc. Am. Soc. Clin. Oncol. , vol.17 , pp. 257
- De Gramont, A.¹ Figer, A.² Seymour, M.³ Homerin, M.⁴ Le Bail, N.⁵ Cassidy, J.⁶ Boni, C.⁷ Cortes-Funes, H.⁸ Freyer, G.⁹ Hendler, D.¹⁰ Louvet, C.¹¹

43
- 0000389059
- Weekly irinotecan (CPT-11), leucovorin (LV), and fluorouracil (FU) is superior to daily x5LV/FU in patients (PTS) with previously untreated metastatic colorectal cancer (CRC)
- abs898
- (1999) Proc. Am. Soc. Clin. Oncol. , vol.18 , pp. 233
- Saltz, L.B.¹ Locker, P.K.² Pirottan, N.³ Elfring, G.L.⁴ Miller, L.L.⁵

44
- 0000025843
- A randomized phase III trial comparing irinotecan (IRI) + 5FU/folinic acid (FA) to the same schedule of 5FU/FA in patients (pts) with metastatic colorectal cancer (MCRC) as front line chemotherapy (CT)
- abs899
- (1999) Proc. Am. Soc. Clin. Oncol. , vol.18 , pp. 233
- Douillard, J.Y.¹ Cunningham, D.² Roth, A.D.³ Germa, J.R.⁴ James, R.D.⁵ Karasek, P.⁶ Jandik, P.⁷ Iveson, T.⁸ Carmichael, J.⁹ Gruia, G.¹⁰ Dembak, M.¹¹ Sibaud, D.¹² Rougier, P.¹³

45
- 0028151449
- The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer
- (1994) J. Clin. Oncol. , vol.12 , pp. 2640-2647
- Johnston, P.G.¹ Fisher, E.R.² Rockette, H.E.³ Fisher, B.⁴ Wolmark, N.⁵ Drake, J.C.⁶ Chabner, B.A.⁷ Allegra, C.J.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.